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The process of electron transfer from NADPH-cytochrome P450
reductase to cytochromes P450 constitutes an essential step in the
catalytic cycle ofmicrosomal cytochromes P450. Its critical importance
in determining the catalytic efﬁciency and coupling of the microsomal
monooxygenase has prompted a sustained interest in the mechanistic
and kinetic aspects of the NADPH-dependent electron ﬂow to
cytochromes P450. However, although the kinetics of NADPH-
dependent reduction has been studied for over 40 years, [1–8], the
detailed mechanisms remain obscure.
The reduction kinetics in microsomal membranes and in most
model systems are biphasic, with the rate constant of the two
exponential phases differing by over an order of magnitude [2,3,6,8].
Although there is no commonly accepted hypothesis on the
mechanism of this biphasicity, its close connection to the position ofP450 spin equilibrium is beyond doubt. In most cases, displacement of
the spin equilibrium towards the high-spin state caused by addition of
Type I substrates increases the fraction of the fast phase [2,4,5,7].
Furthermore, in some cases, the ﬁrst exponential phase of reduction
was shown to represent solely the reduction of the high-spin heme
protein [5,6]. These observations are difﬁcult to explain in view of the
extremely rapid rate of spin transitions [9–11], so that the spin
equilibrium is expected to remain unchanged during the reduction. It
appears likely that this apparent discrepancy reveals a persistent
conformational heterogeneity of the heme protein [6,12] that causes a
divergence of the enzyme into two stable populations with different
positions of the spin equilibrium and different rates of reduction.
Recent advances in X-ray crystallography of membranous cyto-
chromes P450 have provided solid support for a vast conformational
mobility in several of these heme proteins (see [13] for a review). This
mobility is thought to play a pivotal role in substrate-dependent
modulation of the functional properties of the enzyme and in the
mechanisms of the substrate-induced spin shift and cooperativity in
particular [14]. However, despite the fact that the functional catalytic
unit of the monooxygenase system is represented by a complex of
cytochrome P450with (reduced) NADPH-cytochrome P450 reductase
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conformational effects of P450 interactions with these redox partners.
Moreover, the effect of the redox state of the electron carrier partners
of P450 on their interactions with P450 remains completely
unexplored. This fact calls into question the relevance of known
effects of the interactions of P450 with oxidized CPR and b5 on spin
equilibrium of P450 and its afﬁnity for substrates (see [15] for a
review) to the functionally competentmonooxygenase system, where
both CPR and b5 are presumed to be represented by their reduced
states.
Another important question that remains unresolved is the
structural and functional consequences of association of several P450
molecules to yield P450 oligomers. Numerous experimental observa-
tions reveal a considerable degree of homo- and hetero-oligomerization
of cytochromesP450 in theendoplasmic reticulum(see [16] for review).
In particular, oligomerization of cytochromes P450 in membranes was
evidenced by rotational diffusion measurements in various implemen-
tations [17–22], freeze-fracture electron microscopy [20], immuno-
chemical cross-linking [23], and inter-molecular FRET studies
employing the P450 enzymes fused with ﬂuorescent proteins [24].
Homo- and hetero-oligomerization of cytochromes P450 in the
membrane may play an important functional role (see [14,16,25] for
review). According to our hypothesis [14], the conformational and/or
steric consequences of the P450–P450 interactions in theoligomersmay
represent the primary cause of persistent conformational heterogeneity
of the enzyme in themembrane, which is known to be tightly related to
the mechanisms of heterotropic cooperativity in CYP3A4 [26–29]. Such
oligomerization-promotedheterogeneitymayhave aprominent impact
on the kinetics of electron transfer to cytochromes P450 [12,29,30].
An important impediment in interpretation of the kinetics of
electron transfer in membranous systems at varying surface density of
proteins is the difﬁculty in discrimination of the effects on the kinetics of
intracomplex electron transfer from the changes in the concentration
of the electron-transfer complexes. Membrane-incorporated systems
provide no simple and adequate way to monitor and vary the
concentration of the protein–protein complexes. A mixed artiﬁcial
system, where the electron donor partner of a membrane-incorporated
P450 is localized in the aqueous phase, may represent amodel of choice
for these studies. The use of a soluble ﬂavoprotein partner, such as the
ﬂavin domain of P450BM-3 from Bacillusmegaterium (BMR), eliminates
the need for co-incorporation of the electron donor protein into the
membrane and allows using a simple titration approach to determine
the dissociation constant of the electron transfer complex. Localization
of BMR in the aqueous phase also makes it possible to ensure an
unchanged degree of P450 saturationwith the ﬂavoprotein at changing
P450 surface density and to study the process of electron transfer at
complete saturation of the heme protein with the reductase.
BMR shares 35% identity and 56% similarity to rat CPR with highly
conserved segments involved in the binding of the ﬂavins and pyridine
nucleotide. The cluster of negative charges located at positions 207–215
in the FADdomain,which is believed to participate in the interactions of
the rat microsomal reductase with cytochromes P450 [31], is also con-
served in BMR (residues 647–655 in the FAD domain of the P450BM-3
sequence). A close resemblance of the mechanisms of interactions of
CPR and BMR with microsomal cytochromes P450 is also supported by
the ﬁnding that these two ﬂavoproteins exhibit similar afﬁnities and
identical ionic strength dependencies in their interactions with rabbit
microsomal cytochrome P450 2B4 (CYP2B4) [32]. An important
distinction between P450-BM3 and mammalian cytochrome P450-
reductase pairs is the difference in the electron-donating species of the
ﬂavins. In the microsomal systems the two-electron reduced state of
FMN, FMN hydroquinone (FMNH2), is thought to serve as the electron
donor for cytochrome P450. However, electron transfer in the bacterial
cytochrome P450–BM3 takes place from the one-electron reduced form
of FMN, the anionic semiquinone (FMN•−) [33]. Despite this difference,
BMRwas found to be an efﬁcient electron donor to several mammaliancytochromes P450 [34,35]. However, it is unclear whether the FMN
semiquinone anion of BMR is the electron-donating species in these
unnatural redox pairs, or whether the electrons are rather transferred
from the FMN hydroquinone of BMR, similar to the natural pairs of CPR
with microsomal cytochromes P450.
An artiﬁcial fusion protein consisting of BMR and human CYP3A4
domains has been recently constructed and shown to be active in the
catalysis of CYP3A4-speciﬁc monooxygenation reactions. The turn-
over numbers exhibited by this catalytically self-sufﬁcient chimera
are close to those characteristic of CYP3A4 in reconstituted systems
with rat CPR [34]. Therefore, BMR appears to be an appropriate
substitute for the native ﬂavoprotein of CYP3A4 in the model systems.
In a recent study of the kinetics of electron transfer in the complexes
of BMR with oligomeric CYP3A4 in solution we demonstrated that the
overall reducibility of CYP3A4 by BMR did not exceed 50% either in the
absence of substrates or in the presence of bromocriptine, pyrenebu-
tanol, or testosterone. At the same time, the reducibility of the high-spin
fraction of the enzymewasalways complete, so that the ferric CYP3A4 at
the endof reduction processwas represented by the low-spin formonly
[29]. Interestingly, the allosteric activator of CYP3A4α-naphthoﬂavone
(ANF) increased CYP3A4 reducibility, supporting a link between
functional and conformational heterogeneity of CYP3A4 and hetero-
tropic cooperativity. We also noticed a rapid displacement of the spin
equilibrium of the ferric hemoprotein caused by the addition of NADPH
to the complexes of CYP3A4 with BMR. This observation may reveal an
important modulation of the spin state and redox properties of the
hemeprotein by the state of reductionof the boundﬂavoproteinpartner
[29].
In the present study we probe the effect of the state of CYP3A4
oligomerization on the reducibility of the heme protein by BMR by use
of nanoscale lipoprotein bilayer constructs (Nanodiscs), where the
membrane-incorporated CYP3A4 is monomeric [36]. We also took
advantage of the functionally homogenous and monomeric Nanodisc
system to investigate the effect of the reduction of BMR ﬂavins on the
spin state of CYP3A4 associatedwith the ﬂavoprotein. In our studies of
the effect of P450–P450 interactions on its reducibilitywe also employ
CYP3A4-containing proteoliposomes with different surface density of
the heme protein. Whereas in liposomes with high surface density of
CYP3A4 the enzyme is presumed to be severely oligomerized,
decreased surface density of CYP3A4 in lipid-rich liposomes must
result in a displacement of the oligomerization equilibrium towards
monomers. Dissociation of CYP3A4 oligomers in the membranes of
lipid-rich liposomes is demonstrated here by lifetime FRET measure-
ments using a mutant of CYP3A4 with a single SH-reactive cysteine
(CYP3A4(C468)) that was labeled with a BODIPY probe.
2. Materials and methods
2.1. Materials
NADPH, 3,4-dihydroxybenzoic (protocatechuic) acid, protocatechu-
ate-3,4-dioxygenase fromPseudomonas sp., bromocriptinemesylate, 3-
sn-phosphatidic acid (PA) sodium salt from egg yolk, 3-sn-phosphati-
dylethanolamine (PE) from bovine brain, and L-α-phosphatidycholine
(PC) from egg yolk were the products of Sigma Aldrich Chemicals
(St. Louis, MO). α-Naphthoﬂavone (ANF) was from Indoﬁne Chemical
Company (Hillsborough, NJ). Octyl-β-D-glucopyranoside (octylgluco-
side, OG) was obtained from Fluka (Switzerland). 2-Decanoyl-1-(O-
(11-(4,4-diﬂuoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-pro-
pionyl) amino) undecyl)-sn-glycero-3-phosphocholine (BODIPY-PC),
1-hexadecanoyl-2-(1-pyrenedecanoyl)-sn-glycero-3-phosphocholine
(pyrene-PC), N-(4,4-diﬂuoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-inda-
cene-3-yl)methyl)iodoacetamide (BODIPY-FL iodoacetamide), and 1-
pyrenebutanol (1-PB) were purchased from Invitrogen/Molecular
Probes Inc. (Eugene, OR). 4,4-Diﬂuoro-1-carboxymethyl-4-bora-3a,4a-
diaza-s-indacene (CM-BODIPY) was a generous gift of Prof. Gelii
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Russia). All other chemicals were of ACS grade and were used without
further puriﬁcation.
2.2. Expression and puriﬁcation of CYP3A4 and BMR
CYP3A4 was expressed as the His-tagged protein in Escherichia coli
TOPP3 [37]. The enzyme was puriﬁed to electrophoretic homogeneity
by the three-column procedure described earlier [38] except that the
Macro-Prep High S resin was replaced with Macro-Prep CM Support
(Bio-Rad Laboratories, Hercules, CA), which yielded better purity and
yield of the protein. This procedure yields enzyme with a ratio of
absorbance at 418 and 280 nm (A418/280) of 1.50–1.55, which is close
to the theoretical value of 1.62 expected for the pure low-spin CYP3A4
holoprotein. The preparations were stored at−80 °C as 100–150 µM
solutions in 100 mM HEPES buffer (pH 7.4), containing 10% glycerol
(v/v), 3 mM tris(2-carboxyethyl)phosphine (TCEP), and 1 mM ethy-
lenediaminetetraacetic acid (EDTA). Expression of BMR in E. coli BL21
(DE3) cells and puriﬁcation of the protein was performed as described
earlier [29].
2.3. Preparation of the cysteine-depleted C58T/C64A/C98S/C239S/
C377S mutant of CYP3A4 (CYP3A4(C468))
CYP3A4(C468) mutant was generated using the QuikChange site-
directedmutagenesis kit and a template consisting of the N-terminally
truncated (Δ3–12) and tetrahistidine-tagged CYP3A4wild-type cDNA
by consecutive single-cysteine replacements to yield C58T/C64A/
C98S/C239S/C377S as described in [38]. The protein was expressed in
E. coli and puriﬁed as described above for the wild-type enzyme.
2.4. Labeling of CYP3A4(C468) by BODIPY(FL) iodoacetamide
Labeling of the protein was performed essentially as described
earlier [38]. After removal of TCEP from the stock solution of CYP3A4
(C468) by dialysis against 100 volumes of 100 mM Na-Hepes buffer,
pH 7.4, containing 10% glycerol (v/v)) under constant argon bubbling,
the protein was diluted to the concentration of 10 µM by addition of
the same buffer containing 0.2% Igepal CO-630. Labeling was
performed by incubation of the protein at constant stirring under
argon atmosphere in the presence of 20 µM BODIPY-FL iodoacetamide
and 20 µM CM-BODIPY at room temperature. Addition of the latter
non-reactive water-soluble BODIPY derivative was found to increase
the degree of labeling (see below). The process of modiﬁcation, which
was monitored by increase in the ﬂuorescence of the label, took about
40 minutes, after which time no further increase in the ﬂuorescence
intensity was observed. The reaction was stopped by addition of a 1 M
solution of DTT to the ﬁnal concentration of 2 mM. The detergent and
the unbound probe were removed from the sample by washing on a
Ni-agarose column (1 ml of the gel per 40 nmol of the enzyme). As
determined from the UV–Vis absorbance spectra, the degree of
labeling of the protein achieved with the above procedure was usually
around 50%. It should be noted that the degree of labeling that could
be achieved in the absence of CM-BODIPY, a non-reactive water-
soluble BODIPY derivative, did not exceed 25%–30%. This effect of CM-
BODIPY may be explained by its competition with BODIPY-FL for the
interactions with the CYP3A4 substrate-binding site and/or hydro-
phobic patches on the protein surface. Displacement of BODIPY-FL
from the complexes with the enzyme by CM-BODIPY may promote
the modiﬁcation by increasing the actual concentration of the SH-
reactive probe.
2.5. Preparation of Nanodiscs containing CYP3A4
Soluble nanoscale membrane bilayer particles (Nanodiscs) con-
taining CYP3A4 were obtained by a detergent-removal techniquefrom the mixture of CYP3A4, phospholipid and a membrane scaffold
protein (MSP1D1), as described previously [39]. Brieﬂy, the mem-
brane scaffold protein (MSP1D1) had been incubated with TEV
protease to remove its histidine tag [39] and mixed with puriﬁed
CYP3A4, palmitoyl oleoyl phosphatidyl choline (POPC), and sodium
cholate at a 10:1:650:2000 molar ratio. Removal of detergent by
treatment with Amberlite beads initiated a self-assembly process,
which resulted in formation of a CYP3A4-containing discoidal POPC
bilayer particles (∼10 nm in diameter) stabilized by the amphipathic
MSP1D1 belt [40,41]. The discs were puriﬁed over a Sephadex G-200
size exclusion column to remove any partially formed discs, and on a
Ni-NTA column to remove any empty Nanodiscs.
2.6. Preparation of proteoliposomes
Proteoliposomes were prepared by incorporation of CYP3A4 into
pre-formed liposomes prepared with the octylglucoside/dialysis
technique. We used a 2:1:0.6 mixture of PC, PE and PA with addition
of 1 µg of BODYPY-PC per mg of lipid mixture. BODIPY-labeled
phospholipid was included in the mixture for easy detection of the
liposomes during their separation by gel ﬁltration. This ﬂuorescent
phospholipid derivative was replaced with pyrene-PC in the prepa-
ration of the liposomes for the experiments with BODIPY-labeled
CYP3A4(C468). Lipids (10 mg) were mixed as chloroform solutions,
and the solvent was removed by evaporation under a stream of argon
gas and subsequent drying under vacuum for 2 h. The suspension of
lipids in 2.5 ml of 100 mM HEPES, 150 mM KCl, 0.5 mM EDTA,
containing 10% (v/v) glycerol, pH 7.4 (Buffer A) containing 1.54%
octylglucoside was prepared using a vortex mixer and incubated for
30 min at room temperature under argon. The mixture was then
diluted with the same buffer containing no detergent to the ﬁnal
concentration of octylglucoside of 0.43%. The mixture was dialyzed at
4 °C under constant gentle bubbling of argon gas against three
changes of 500 ml of buffer A, each containing 0.5 g of Bio-Beads
hydrophobic adsorbent (Bio-Rad Laboratories, Hercules, CA). After
72 h of dialysis (24 h per each portion of the buffer) the mixture was
concentrated on 300 kDa cut-off Diaﬂo membranes (Millipore,
Billerica, MA) to a phospholipid concentration of 8–10 mM and stored
at −80 °C under argon. To incorporate cytochrome P450 into pre-
formed liposomes a solution of puriﬁed CYP3A4 (100–150 µM) was
added to an 8 mM suspension of the liposomes in Buffer A containing
1 mM DTT to reach a protein-to-lipid molar ratio of 1:50 (LPS-76) or
1:500 (LPS-910). Separation of proteoliposomes from unincorporated
CYP3A4 was performed by gel ﬁltration on a 1.2×40 cm column of
ToyopearlHW-75 resin (TosohBioscienceGmbH, Stuttgart, Germany).
The ratio of P450 to phospholipid in the column throughput solution
was assessed by the ratio of optical densities at 418 and 506 nm (or
418 and 343 nm in the case of the liposomes containing pyrene-PC).
The fractions with a ratio differing by no more than 25% were pooled
and concentrated to a CYP3A4 concentration of 20–30 µM. The molar
ratio of phospholipids to cytochrome P450 in the ﬁnal preparationwas
estimated based on the determination of total phosphorus in
chlorophorm/methanol extract according to Bartlett [42]. The pre-
parations of the proteoliposomes were stored at−80 °C under argon
atmosphere.
2.7. Scanning stop-ﬂow kinetic experiments
We used a rapid-scanning MC2000-2 CCD-spectrometer (Ocean
Optics, Inc., Dunedin, FL) combined with a SF-MiniMixer Stopped-Flow
apparatus (KinTek Corporation, Austin, TX) as described earlier [12].
Anaerobiosis was achieved using an oxygen-scavenging system
consisting of protecatechuate-3,4-dioxygenase (0.5 units/ml) and
5 mM protocatechuic acid. The reaction was initiated by mixing equal
volumes of (i) the solution of CYP3A4 and BMR and (ii) a 0.4 mM
solution of NADPH containing glucose-6-phosphate dehydrogenase
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studied in the presence of substrates, 1-PB or ANF was added to both
syringes of the stop-ﬂow apparatus to the concentration of 30 µM. All
experimentswere performed at 25 °C in 100 mMHEPES buffer (pH 7.4)
containing 1 mM DTT and 1 mM EDTA.
2.8. Fluorescence spectroscopy
Time-resolved ﬂuorescence spectroscopy (TRFS) measurements
were performed in a 100 µl 10×2 mm ultra-micro ﬂuorescence cell
(Hellma GmbH & Co. KG, Müllheim, Germany, Product #105.250)
with a FLS 920 ﬂuorescence lifetime spectrometer from Edinburgh
Instruments (Edinburgh, UK). The spectrometer was equipped with a
PDL 800-D pulsed diode laser driver and a LDH405 laser head from
Picoquant GmbH (Berlin, Germany) as a light source. Fluorescence
excitation was performed at 405 nm and ﬂuorescence decay curves
were monitored at 520 nm with a 100 ns time span. Fitting of the
decay traces was made with the F900 Fluorescence Spectrometer
Software (Edinburgh Instruments) using the deconvoluted bi-expo-
nential ﬁt mode, which takes into account the instrument response
function (IRF). IRF was measured by registering the decay traces
at the wavelength of excitation with a Teﬂon diffuser placed into
the cell holder.
Steady-state ﬂuorescence measurements were done using an
MC2000-2 multi-channel CCD rapid-scanning spectrometer (Ocean
Optics, Inc., Dunedin, FL, USA) equipped with one ﬂuorescence and
one absorbance channels. Excitation of BODIPY ﬂuorescence was
performed at 405 nm using an LDH405 pulsed diode laser. Simulta-
neous control of the changes in the absorbance of the sample was
performed employing the second (absorbance) channel of the
spectrometer and using an OSRAM 64614 UV-enhanced tungsten
halogen lamp (OSRAM, Germany) as a light source. Alternating the
light sources during the measurements was achieved with computer-
controlled FOS-2-inline ﬁber optic switch from Avantes (Eerbeek, The
Netherlands).
In order to prevent the oxidation of the lipids of the membrane
during our lengthy FRET experiments with the liposomes, these
experiments were performed under anaerobiosis, which was attained
with argon bubbling and the use of the oxygen-scavenging system
with protecatechuate-3,4-dioxygenase, as described above.
2.9. Data processing
The series of absorbance spectra obtained in kinetic experiments
were analyzed using principal component analysis (PCA) combined
with the ﬁtting of the principal component spectra to a set of spectral
standards, as described previously [12,43,44]. Brieﬂy, the PCA
procedure was applied to a set of difference spectra obtained by
subtraction of the ﬁrst spectrum in the series (zero time point) from
all subsequent spectra. To interpret the resulting series in terms of the
changes in concentrations of the ferric low-spin, ferric high-spin, and
the ferrous carbonyl complexes of P450 and P420 states of the heme
protein, the principal vectors were approximated with a linear
combination of the respective spectral standards combined with a
low-order (≤4) polynomial function. The latter was introduced to
compensate for the baseline ﬂuctuations during the experiment. The
high-ranking components characterized by a square correlation
coefﬁcient (ρ2) above the threshold, which was set to 0.5 in most
cases, were considered signiﬁcant and used to calculate the changes in
the concentrations of the P450 species. This technique was described
in detail earlier [43,44]. The set of spectral standards consisted of the
spectra of ferric low- and high-spin P450 species of CYP3A4 [28] and
the spectra of the carbonyl complexes of ferrous P450 and P420 states
of CYP3A4. The latter were reﬁned by studying the pressure-induced
P450-to-P420 conversion of the CYP3A4 ferrous carbonyl complex,
similarly to the technique used for CYP2B4 and CYP1A2 [45,46]. Thecomplete set of the standards used in this study are available on-line
as Supporting Information to our recent publication [29]. These
kinetic curves were ﬁtted to a multiexponential equation using a
combination of Marquardt and Nelder-Mead algorithms. All data
ﬁtting and spectral analysis procedures were performed using our
SPECTRALB software [43].
3. Results
3.1. Interaction of BMR with CYP3A4
In designing our kinetic experiments we sought to examine the
kinetics of intracomplex electron transfer under conditions of
complete saturation of CYP3A4 with the ﬂavoprotein. This setup
requires knowledge of the dissociation constant of the complex of
BMR with CYP3A4-incorporated into Nanodiscs or proteoliposomes.
Our approach to determination of these dissociation constants was
based on the known fact that the formation of the complexes of
cytochromes P450 with CPR results in a displacement of the spin
equilibrium of the heme protein, which is reﬂected in the changes in
UV–Vis absorbance similar to those observed for the binding of Type-I
substrates [47–49].
In order to increase sensitivity of the assays and resolve the
absorbance bands of CYP3A4 from those of the ﬂavoprotein we
employed the technique of a tandem cell (“counter-ﬂow”) continuous
variation titration [50], similar to that described in our study with
CYP3A4 in solution [29]. At the beginning of these experiments the
ﬁrst and the second compartments of a tandem cell contained equal
volumes of equimolar solutions of BMR and either CYP3A4–ND or
CYP3A4 incorporated into the proteoliposomes. Mixing of the
interacting proteins was achieved by reciprocal gradual displacement
of small aliquots of the solutions between compartments, so that the
molar fraction of CYP3A4 in the ﬁrst compartment (F1) increased from
0 to 0.5, concomitant with a decrease in this fraction from 1 to 0.5 in
the second compartment. As discussed in [50], in the case of the
formation of 1:1 complexes between the interacting proteins, the
titration curves obtained in this way are equivalent to the ascending
branch of the symmetric bell-shaped curve characteristic of the
traditional Job's titrations. In addition to probing the stoichiometry of
complex formation, this setup considerably increases the accuracy of
titrations by eliminating the spectral signal of the reductase, so that
the observed spectral changes reﬂect the changes in the absorbance of
the heme protein only.
A series of spectra obtained in a counter-ﬂow continuous variation
experiment with 5 µM CYP3A4-containing proteoliposomes (LPS-76)
is shown in Fig. 1a. As seen from this ﬁgure, a stepwise mixing of the
equimolar solutions of LPS-76 and BMR results in a decrease of the
amplitude of the low-spin CYP3A4 Soret band at 418 nm concomitant
with increase in the absorbance band at 380–400 nm. This BMR-
induced transition in CYP3A4 is attributable to a low-to-high-spin
shift, as expected according to published observations [47–49].
However, detailed analysis of the spectrum of the ﬁrst principal
component of the changes (Fig. 1a inset) reveals some deviations
from the shape characteristic of a canonical low-to-high-spin shift. In
particular, the position of the main maximum of the spectrum is
shifted to wavelength shorter than expected (388 nm) and the
amplitude of this maximum is lower than that anticipated from the
amplitude of the trough at 420 nm. It should be noted, however, that
the spectra reported by French et al. for the interactions of CYP2B4
with CPR in the absence of substrate ([47], Fig. 5A, inset) may be also
indicative of a similar deviation.
A series of titration curves obtained with various concentrations of
LPS-76 are shown in Fig. 1b. Here the abscissa represents the molar
fraction of BMR in the ﬁrst compartment of the tandem cell, while the
ordinate shows the amplitude of the observed decrease in the mean
concentration of the low-spin heme protein in the two compartments.
Fig. 1. Formation of the CYP3A4 complexes with BMR studied by counter-ﬂow (tandem cell) continuous variation titration. The interactions were monitored by the changes in the
concentration of P450 low-spin and high-spin states. Panel a shows a series of spectra obtained in the experiment with CYP3A4 containing liposomes (LPS-76) at a concentration of
5 µM. The inset represents the spectrum of the ﬁrst principal component obtained by PCA. The dashed line shows the approximation of this spectrum by the set of CYP3A4
absorbance standards. Panel b shows a series of titration curves obtained with LPS-76 and BMR taken at the concentrations of 5 (circles), 2.6 (triangles), 1.1 (squares) and 0.8 µM
(diamomds). Panel c represents a series obtained with CYP3A4-ND and BMR at concentrations of 5.3 (circles), 2.6 (triangles), and 1.3 µM (squares). Solid lines represent the results
of the ﬁtting of the data sets to the equation for the equilibrium of bimolecular association suited to the case of the counter-ﬂow titration (Eq. (3) in [50]).
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complex. Global ﬁtting of this data set to the equation for the
equilibrium of bimolecular association suited to the case of the
counter-ﬂow titration (Eq. (3) in [50]) gives the KD values of CYP3A4–
BMR complex of 0.14±0.08 µM and the maximal amplitude of the
BMR-induced spin shift of 26.5±6%. Similar results were also
obtained with CYP3A4–ND (Fig. 1c), where the dissociation constant
and the maximal spin shift amplitude were equal to 0.10±0.05 µM
and 11.5±0.5%.
Therefore, similar to CYP3A4 in solution [29], the heme protein
incorporated in to the lipid bilayer in either proteoliposomes or
Nanodiscs interacts with BMR with the formation of 1:1 complexes.
The values of dissociation constants of these complexes suggest that
at the concentrations of CYP3A4 and BMR used in our kinetic
experiments (1.5–3 and 3–6 µM respectively), the whole pool of the
heme protein is represented by the complexes with its ﬂavoprotein
partner.
3.2. Spectral changes in BMR during its NADPH-dependent reduction
Since ﬂavins exhibit absorbance spectra overlapping those of
cytochrome P450 and that are highly dependent on the state of
reduction, spectral studies of the process of reduction of cytochrome
P450 in the presence of excess BMR require a detailed knowledge of
the spectral transitions of the ﬂavoprotein upon its reduction. In order
to obtain a set of spectral standards characterizing these changes we
examined the kinetics of NADPH-dependent reduction of the
ﬂavoprotein by rapid-scanning stop-ﬂow spectrometry. It should be
noted that we did not intend to repeat the analysis of the process of
BMR reduction, which was done in ﬁne detail by Sevrioukova et al.
[51]. The only purpose of our studies of BMR reductionwas to obtain a
set of prototypical differential spectra (spectral standards) whichmay
be used to discriminate the transitions in cytochrome P450 from those
in the reductase.
As the process of BMR reduction is very rapid [51], these
experiments were performed at 5 °C for better resolution of spectral
changes. As seen from Fig. 2a, the ﬁrst spectrum of the series is alreadycharacterized by a substantially decreased absorbance band of the
ﬂavoprotein at 455 nm, as compared with the absorbance spectra of
the oxidized BMR (see Fig. 1a in [51]). This decrease in the ratio of the
ﬂavin bands at 380 and 456 nm is indicative of formation of the
reduced anionic red semiquinone form of FMN [51], which takes place
during the dead time of the instrument (∼2 ms). During the initial
phase of monitoring, a decrease in the absorbance band at 456 nm
continues, while the absorbance at 380 nm remains virtually
unchanged. During the following, slower phase of the reduction, a
decrease in the absorbance at 380 nm indicates the formation of the
ﬂavin hydroquinone. No considerable absorbance band of the neutral
blue ﬂavin semiquinone around 550–600 nm was observed in our
experiments, demonstrating that the anionic ﬂavin semiquinone is
the predominant semiquinone state of FMN in BMR, in agreement
with previous observations [51,52]. It should be noted that, due to
very low extinction coefﬁcients of the blue semiquinone absorbance
band (λmax≈550 nm) and the charge transfer band of the BMR
complex with NADPH (λmax≈750 nm), we made no attempt to
resolve negligibly small alterations of BMR absorbance caused by the
changes in the concentration of these species. These changes, which
were characterized in detail by Sevrioukova et al. [51], are negligible
compared with the changes in CYP3A4 absorbance and may be
ignored in the spectral analysis of the CYP3A4 reduction process.
Application of PCA reveals two signiﬁcant principal vectors, which
cover over 99.5% of the spectral changes (Fig. 2b). These principal
vectors were obtained by global analysis of a series of sets of spectra
obtained in four independentmeasurements andwere used to resolve
BMR- and CYP3A4-related spectral changes in the analysis of the
results of our CYP3A4-reduction experiments (see below). The ﬁrst
principal component reﬂects a decrease in the amplitudes of both 380
and 450–470 nm bands, which is indicative of the formation of the
hydroquinone or neutral semiquinone forms of the ﬂavin. In contrast,
the long-wavelength and short-wavelength branches of the second
principal vector have opposite signs, so that a simultaneous increase
in the loading factors of both principal vectors represents a decrease
in the 456-nm band only. This simultaneous increase observed during
the initial phase of the reduction represents the formation of red,
Fig. 2. Kinetics of NADPH-dependent reduction of BMR recorded with a rapid-scanning stop-ﬂow technique. Conditions: 20 µM BMR, 0.2 mM NADPH in 0.1 M Na-Hepes buffer, pH
7.4, 1 mMDTT, 1 mM EDTA containing NADPH-generating and oxygen-scavenging systems (see Materials andmethods), 5 °C. Spectra recorded in a stop-ﬂow cell with 5 mm optical
path length. a: Absorbance spectra of BMR taken during the reduction. The ﬁrst spectrum corresponds to ∼2 ms after addition of NADPH. b: The spectra of the ﬁrst (solid line) and
the second (dashed line) principal components found by PCA applied to a manifold of 5 series of spectra obtained in independent experiments. Panels c and d show the changes in
absorbance at 455 and 385 nm respectively. Data points in circles correspond to the data set obtained at 5 °C shown in panel a. The data points shown in triangles in panel d
represent a similar experiment at 25 °C. Solid lines show the results of ﬁtting of the kinetic curves by a ﬁrst-order kinetic equation.
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(Fig. 2c) obeys a simple ﬁrst-order reaction equation with a rate
constant of 23±8 s−1, which is consistent with the value of 27 s−1
reported by Sevrioukova et al. as a rate constant of the formation of
[NADPH+, FADH•, FMN•−] state [51]. The slow phase of the reduction,
which is characterized by a rate constant of 0.019±0.08 s−1 is
attributable to the appearance of the three- and/or four-electron
reduced BMR that contains ﬂavin hydroquinone(s). At 25 °C this rate
constant increases 10 times and reaches 0.16±0.03 s−1 (Fig. 2d),
while the rate constant of the fast phase increases to approximately
30–60 s−1 and becomes too high to be determined with our
technique (data not shown).
3.3. Kinetics of CYP3A4 reduction in Nanodiscs
A series of spectra taken after addition of NADPH to the mixture of
CYP3A4–ND with BMR reﬂects both the reduction of BMR ﬂavins anda consequent electron transfer to the heme protein (see Fig. S1 in the
Supporting material). In order to analyze the changes in the
concentrations of the individual P450 states (ferric high- and low-
spin states and the ferrous carbonyl complexes of both P450 and P420
forms of CYP3A4) we used a PCA-based procedure designed to
separate the spectral changes in the heme protein from those in the
ﬂavins. Application of PCA to the series of raw spectra taken in the
process of reduction resulted in two principal components which
cover over 99.5% of the spectral changes. The principal components
were approximated by a linear combination of the standard
differential spectra of CYP3A4 reduction complemented with the
two differential spectra reﬂecting the process of BMR reduction (see
above). The results of this approximation (ρ2≥0.99) were used to
eliminate the changes in the ﬂavin-speciﬁc bands from the experi-
mental spectra.
A series of differential spectra reﬂecting the changes in CYP3A4–ND,
which was obtained in this way, is exempliﬁed in Fig. 3a and b. A
Fig. 3. Kinetics of BMR-dependent reduction of CYP3A4–ND in the absence of substrate. Conditions: 2.6 µM 3A4, 5.2 µM BMR, 0.2 mM NADPH, CO-saturated 0.1 M Na-Hepes buffer,
pH 7.4, 1 mM DTT, 1 mM EDTA containing oxygen-scavenging and NADPH-generating systems (see Materials and methods), 25 °C. Spectra recorded in a stop-ﬂow cell with 5 mm
optical path length. a, b: Changes in absorbance in the Soret region during the reduction. The spectrum measured at time of origin is subtracted. Panel b scales up the spectra
representing the ﬁrst 14 seconds after mixing. c: The time course of the changes in the concentrations of the carbonyl complexes of CYP3A4(Fe2+) P450 (squares) and P420 states
(diamonds), their total (triangles), as well as the low-spin (circles) and the high-spin (inverted triangles) states of CYP3A4(Fe3+). The dashed line indicates the total concentration of
CYP3A4. Panel d shows the initial part of the kinetic curves for the low-spin (circles) and the high-spin (inverted triangles) states of CYP3A4(Fe3+).
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the band of absorbance of ferrous carbonyl CYP3A4 at 448 nm is
associated with a profound decrease in the band centered around
390 nm, which suggests a major decrease in the concentration of the
high-spin P450. This is quite unexpected, as the content of the high-spin
hemeprotein in thepresenceof BMRat no substrate addedwas found to
be as low as 5% (Fig. 1). Therefore, theﬁrst spectrumof the series, which
was taken during the ﬁrst 2–3 ms after themixing (the dead time of the
instrument) and used as a base for the difference spectra shown in Fig. 3,
appears to be highly enriched in the high-spin state compared with the
oxidized enzyme without NADPH. Furthermore, the spectra taken
during the initial phase of reduction (∼5 s after the addition of NADPH)
reﬂect rapid kinetics of further conversion of the low-spin P450 to the
high-spin state (Fig. 3b). Correspondingly, the analysis of time changes
in the concentrationof the individual states of CYP3A4 (Fig. 3c) indicates
that the content of the high-spin state of P450 at the end of the dead
timeofmixingwas as high as 41±2%. The initial phase of the changes in
the concentration of the high-spin state (Fig. 3d) exhibits a further
increase, which obeys an exponential equation with a rate constant of1.0±0.2 s−1 (based on the average of the results of 3 individual
experiments). This initial increase paralleled a decrease in the low-spin
content (Fig. 3d), signifying a low-to-high-spin transition takingplace in
the CYP3A4–BMR complex in response to the reduction of BMR.
As seen in Fig. 3d this initial spin shift changes its direction at ∼5 s
after mixing, so that the concentration of the high-spin enzyme starts
to decrease, concomitant with an increase in the low-spin content.
This partial reversal of the initial spin shift is followed by a continuous
decrease in both ferric states due to the reduction of the heme
protein-to-ferrous carbonyl complexes (Fig. 3c). The process of
reduction reﬂected in the appearance of the reduced states of the
heme protein obeys a single-exponential equation with the rate
constant of (2.5±0.2)·10−3 s−1. In contrast, the decrease in the
concentration of the high-spin state is bi-exponential, with a rate
constant of the fast and slow phases of 0.037±0.010 s−1 and (2.4±
0.2)·10−3 s−1, respectively. The dynamics of the low-spin fraction
after the initial rapid spin shift also reﬂects two exponential terms,
although in this case the signs of these terms are opposite. While
the increase in the low-spin between 7 and 20 s after mixing is a
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(k=(2.2±0.3)·10−3 s−1) reﬂects the reduction of the heme
protein.
Therefore, our analysis resolved three consecutive processes
reﬂected in the changes in the concentration of P450 states after
addition of NADPH. The fastest process (k=1.0±0.2 s−1) reﬂects a
low-to-high-spin transition, which is thought to be a result of the
formation of a red ﬂavin semiquinone state of BMR (presumably
[NADPH+, FADH•, FMN•−]), which takes place during the ﬁrst
milliseconds after addition of NADPH (k≥30 s−1, at 25 °C, see
above). The following slow partial reversal of the above spin shift
(k=0.037±0.010 s−1) is apparently caused by the formation of the
completely reduced state of BMR (and, as a result, disappearance of
the anionic semiquinone state), which has a rate constant of 0.16±
0.03 s−1at 25 °C (see above). The third, highest amplitude process
reﬂects the reduction of CYP3A4 with formation of the carbonyl
complexes of the ferrous heme protein.
As seen from Fig. 3 and Table 1, the reducibility of CYP3A4–ND by
BMR is close to 100%, in contrast to incomplete reducibility observed
in the enzyme oligomers in solution. [29]. As seen from Fig. 3c, in
addition to the formation of the ferrous P450 state, reduction of
CYP3A4–ND results in the formation of some amount (≤15%) of P420.
At the end of reduction the concentration of the carbonyl complexes
of these two ferrous states of the enzyme constitute 94±4% of the
total concentration of the heme protein (Table 1). Addition of the
CYP3A4 substrates 1-PB or ANF had virtually no effect on the kinetics
or extent of reduction of CYP3A4–ND by BMR (Table 1). In contrast to
enzyme oligomers in solution, where the addition of ANF improved
the reducibility considerably [29], this effector rather caused a
marginal decrease in the maximal level of reduction in CYP3A4–ND
(Table 1).
3.4. Kinetics of CYP3A4 reduction in proteoliposomes as a function of the
surface density of the enzyme
In order to probe the effect of CYP3A4 oligomerization in the
membrane on its reducibility by BMR we studied the kinetics of
reduction in proteoliposomes with two different lipid-to-protein
ratios. In the ﬁrst preparation, which we designate as LPS-76, the
molar ratio of CYP3A4 to phospholipids was as low as 1:76, whereas in
the second preparation of proteoliposomes, designated as LPS-910,
this ratio was equal to 1:910. This decreased surface density ofTable 1
Parameters of BMR-dependent reduction of CYP3A4 in Nanodiscs and in proteolipo-
somes with various contents of the heme protein.*
System Substrate Fh, %a kf ·103, s−1 b ks ·103, s−1 Ff, % Total
reducibility, %
CYP3A4–ND None 41±2 37±10 2.4±0.2 20±10 93±4
1-PB 38±1 37±5 2.2±0.5 28±4 91±2
ANF 49±4 23±16 3.2±0.9 35±10 79±6
LPS-910 None 36±6 1.8±0.7 83±7
ANF 32±7 0.87±0.5 85±12
LPS-76 None 29±5 111±34 2.4±0.4 33±8 55±6
ANF 55±4 50±13 2.7±0.4 25±4 47±2
*The values given in the table represent the averages of 3–7 individual measurements
and the “±” values show the conﬁdence interval calculated for p=0.05. The kinetic
curves of the decrease in the high-spin state in Nanodiscs and in LPS-76 were ﬁtted to a
bi-exponential equation. In all other cases a mono-exponential equation was used. The
values of kf and ks represent the rate constants of the fast and the slow phases of the
decrease in the concentration of the high-spin ferric state, while the value of Ff
represent the relative amplitude of the fast phase. The rate constants of the changes in
the low-spin ferric and both (P450 and P420) ferrous states were characterized by
values indistinguishable from those of ks within the accuracy of the conﬁdence interval.
a The fraction of the high-spin state at the beginning of the reduction, which is
calculated from the amplitude of the decrease in the high-spin ferric state in the reduction.
b The reducibility is calculated from the increase in the concentrations of the
carbonyl complexes of ferrous P450 and P420 states.CYP3A4 in LPS-910 is presumed to cause a displacement of the
oligomerization equilibrium towards monomers, as compared with
LPS-76 where the enzyme is severely oligomerized. Kinetic curves of
the changes in the concentration of ferric and ferrous states of CYP3A4
after addition of NADPH to the liposomes are shown in Fig. 4. As seen
from this ﬁgure and Table 1, these two preparations differ consider-
ably in the reducibility of CYP3A4 with an amplitude of BMR-
dependent reduction of 55±10% of the total CYP3A4 content in LPS-
76 and a reducibility in LPS-910 as high as 83±10%. This increase in
reducibility upon decreased surface density of the heme protein is
attributed to a high degree of CYP3A4 monomerization in the diluted
membranes as in CYP3A4–ND.
The rapid changes in the spin state of ferric CYP3A4 caused by
reductionofBMR,whichwediscussedabove for the caseof CYP3A4–ND,
are also clearly seen in LPS-76 (Fig. 4a). Similar to CYP3A4–ND, in LPS-76
we observed bi-exponential kinetics of the decrease in the high-spin
content, which follows a very rapid initial low-to-high-spin burst. In
contrast, changes in the concentration of the low-spin state exhibit an
intermittent increase, which is followed by a mono-exponential
reduction phase. In the case of diluted liposomes (LPS-910), this initial
spin shift could not be resolved due to high level of noise in this turbid
system (Fig. 4b). However, even in this case the amplitude of the
observed decrease in the concentration of high-spin state of the enzyme
was considerably higher than the amplitude that could be expected
based on the high-spin content in LPS-910 mixture with oxidized BMR,
which did not exceed 5% (data not shown).
Surprisingly, in contrast to CYP3A4 in solution, addition of ANF to
LPS-76 or LPS-910 had no effect on either reducibility of the enzyme
or the kinetic parameters of reduction. One of the possible explana-
tions for this contrast may be the effect of polar groups of
phospholipids on the interactions of CYP3A4 with BMR, a soluble
enzyme which accesses CYP3A4 from the aqueous phase. These
interactions, which may differ from those of membranous CPR, may
interfere with the effect of substrate in our model system.
3.5. Design of a FRET-based method for probing CYP3A4 oligomerization
In order to probe the state of CYP3A4 oligomerization in liposomes
and validate our conclusion that the differences in the kinetics of
CYP3A4 reduction in LPS-76 and LPS-910 are due to different degrees of
oligomerization of the enzyme, we established a new FRET-based assay
for monitoring the equilibrium of CYP3A4 oligomerization in the
membrane. In these studies we used BODIPY-FL iodoacetamide as the
FRET donor. The spectrumof emission of this probe is characterized by a
broadasymmetric band (λmax=513 nm),whichhas a profoundoverlap
with the α- and β-bands of the CYP3A4 heme, so that the value of R0 of
FRET in BODIPY-heme pair is as large as 62 Å (κ2=2/3). The label is
therefore anticipated to be an efﬁcient donor of FRET to the heme
chromophores located both in the same protein molecule as well as in
the neighboring CYP3A4 subunits in the oligomer. Dissociation of
oligomers is therefore expected to result in a considerable increase in
the intensity and the lifetime of the ﬂuorescence.
To ensure uniform site-speciﬁc labeling of the enzymewe used our
recently developed cysteine-depleted mutants of CYP3A4 [38]. In our
preliminary studies (data not shown) we labeled three mutants that
contain a single reactive cysteine CYP3A4(C64), CYP3A4(C239) and
CYP3A4(468) with BODIPY and found that the highest amplitude of
inter-molecular FRET from the label to the heme in CYP3A4 oligomer
is achieved with CYP3A4(C468). The interactions of this mutant with
BCT, 1-PB, and ANF were very close to those of the wild type CYP3A4
(data not shown).
Measurement of the amplitude of the increase in the domor
ﬂuorescence caused by destruction or abstraction of the acceptor
chromophore (the heme in our case) provides the most accurate
way to probe the efﬁciency of FRET. Destruction of the porphyrin
ring by H2O2 is known as an efﬁcient and gentle approach to deplete
Fig. 4. Kinetics of BMR-dependent reduction of CYP3A4 incorporated in proteoliposomes at a 1:76 (LPS-76, a) or 1:910 (LPS-910, b) molar ratio of CYP3A4 to phospholipids. Reaction
mixtures contained 2.95 (a) and 1.6 µM (b) CYP3A4 in proteoliposomes and a two-fold molar excess of BMR. Other conditions were as indicated for Fig. 3. The panels show the time
course of the changes in the concentrations of the carbonyl complexes of CYP3A4(Fe2+) P450 (squares) and P420 states (diamonds), their total (triangles), as well as the low-spin
(circles) and the high-spin (inverted triangles) states of CYP3A4(Fe3+). The dashed line indicates the total concentration of CYP3A4.
Fig. 5. Kinetics of the changes in the intensity of ﬂuorescence of CYP3A4(C468)–BODIPY
upon its interactions with liposomes. Conditions: 1 μMCYP3A4(C468)–BODIPY in 0.1 M
Na-HEPES buffer, 1 mM DTT, and 1 mM EDTA. Process was initiated by the addition of
the liposomes to yield the L/P ratio of 100 (circles) and 1200 (triangles). Solid lines
show the results of ﬁtting of the kinetic curves with a bi-exponential equation, which
gives the maximal amplitudes of the observed changes of 26% and 78% respectively.
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Therefore, in order to estimate the efﬁciency of FRET from BODIPY
to the heme chromophore we employed the heme depletion
(bleaching) of CYP3A4(C468)–BODIPY in the presence of H2O2.
These experiments, which are illustrated in the Supporting material,
indicated that the efﬁciency of FRET in the oligomers in solution is
equal to 82% (see Fig. S3). Monomerization of the enzyme oligomers
by addition of 0.5% non-ionic detergent Igepal CO-630 results in a 2.5-
fold increase in the ﬂuorescence intensity (Fig. S4). This increase was
accompanied by an increase in the mean ﬂuorescence lifetime, so that
the fraction of the fast phase for bi-exponential approximation of the
decay traces decreases from 81% to 22% upon monomerization of the
enzyme. Consequently, the efﬁciency of FRET from BODIPY to the
heme in the enzyme monomer is decreased to 49%, as determined in
our bleaching experiments (Fig. S4). Therefore, the BODIPY ﬂuor-
ophore in CYP3A4(C468)–BODIPY is involved in FRET to the heme
groups of the neighboring P450 molecules in the oligomer, and the
increase in FRET efﬁciency may be used to monitor the formation of
the enzyme oligomers.
3.6. Probing the equilibrium of CYP3A4 oligomerization in
proteoliposomes with FRET
To probe the monomerization CYP3A4 oligomers upon its
incorporation into the proteoliposomes we studied the changes in
the intensity of BODIPY ﬂuorescence during co-incubation of CYP3A4
(C468)–BODIPYwith different amounts of the liposomes. As shown in
Fig. 5, CYP3A4(C468)–BODIPY interactions with liposomes result in a
time-dependent increase in the intensity of ﬂuorescence, which
reﬂects the process of the protein incorporation into the membrane
and a consequent dissociation of its oligomers. Increase in the lipid-
to-protein ratio results in a considerable augmentation of the effect.
The amplitude of the observed changes in the ﬂuorescence intensity
increases from 26 to 78% upon increase of the L/P ratio from 100 to
1200 (Fig. 5). This difference is consistent with higher degree of
CYP3A4 oligomerization in the liposomes with high surface densities
of the heme protein.
In order to further characterize the degree of oligomerization and
determine the apparent dissociation constant for the enzyme oligomersin proteoliposomeswe employed a series of time-resolved ﬂuorescence
measurements in the liposomeswith different L/P ratio. The changes in
the efﬁciency of FRET were assessed from the fraction of the fast phase
(Ffast) in bi-exponential approximations of the decay traces (τ1=1.1 ns,
τ2=4.9 ns). As seen in Fig. 6a, decrease in the L/P ratio from2000 to 100
boosts Ffast from 40 to 70%. The dependence of Ffast on the surface
density of the heme protein obtained from these experiments (Fig. 6b)
was used to estimate the apparent dissociation constant of CYP3A4
oligomers. Fitting of the experimental results to the equation for the
equilibrium of bimolecular association ([55], p 73, Eq. II-53) yields the
value of the apparent Kd of 1.35±0.06 pmol/cm2 , which is equivalent
to the L/P ratio of 296 . It should be noted, however, that the use of the
above equation in this case is arbitrary. Strictly speaking, the formalism
deduced for the case of multi-molecular reactions in 3-dimensional
space is not directly applicable for the case, where the diffusion of the
Fig. 6. Effect of the surface density of CYP3A4(C468)–BODIPY in proteoliposomes on the
lifetime of ﬂuorescence of the BODIPY probe. The preparations of the proteoliposomes
were obtained by incubation of 1 μM CYP3A4-(C468)–BODIPY with various amounts of
pre-formed liposomes for 1 hour in 0.1 M Na-HEPES buffer, 1 mM DTT, and 1 mM EDTA
at 25 °C. Panel a: A series of normalized ﬂuorescence decay traces (excitation an
405 nm, emission at 520 nm with the band of 18 nm) obtained with L/P ratios of 100,
200, 400, 800, 1400 and 2000. All the curves of the set may be approximated by a sum of
two exponents with characteristic times of 1.1 and 4.9 ns (ρ2N0.95). The inset shows
the traces obtained with L/P ratio of 100 (circles) and 2000 (triangles) in semi-
logarithmic coordinates with ﬁtting curves shown in solid lines. b: Dependence of Ffast
on the concentration of CYP3A4(C468)–BODIPY in the membrane of proteoliposomes.
Data points represent the results of two independent experiments. The solid line
illustrates the ﬁtting of the data set with the equation for the equilibrium of bimolecular
association (KD=1.35±0.06 pmol/cm2).
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Nevertheless, the value of apparent Kd determined above may be used
for a rough estimation of the oligomerization state of CYP3A4 in the
membrane.
To probe the possible effect of CYP3A4 interactions with BMR on
the state of oligomerization of the heme protein we monitored the
ﬂuorescence of CYP3A4(C468)-BODIPY in liposomes with different L/
P ratios as a function of added BMR. The considerable overlap of both
excitation and emission spectra of BODIPY with those of the ﬂavins
precluded the use of the lifetime FRET technique in these experiments.
Therefore,we probed the effect of BMRon the intensity ofﬂuorescence
of CYP3A4(C468)–BODIPY (excitation at 495 nm). In this setup the
bandof BODIPY can be resolved spectrally from theﬂavinﬂuorescence.
These experiments showed that a stepwise increase in the concentra-
tion of BMR from 0 to 20 µM results in a nearly linear low-amplitude
decline in the intensity of BODIPY ﬂuorescence (data not shown). The
amplitude of this decrease does not exceed ∼10–15% at the BMR
concentrations used in our stop-ﬂow experiments. As this effect was
identical in the liposomes with L/P ratios of 150:1 and 1200:1, there isnoobvious change in the CYP3A4oligomerization state in the presence
of BMR.
4. Discussion
The principal conclusion derived from our results concerns the
relationship between the state of aggregation of CYP3A4 and its
reducibility by the ﬂavoprotein. As we demonstrated in our recent
study on BMR-dependent reduction of CYP3A4 in solution, the
reducibility of the enzyme in its oligomers in the absence of substrates
does not exceed 50±9% [29]. We interpreted this ﬁnding as an
indication of conformational heterogeneity of the enzyme caused by
unequal location and/or orientation of the subunits in the oligomer.
The observation that this incomplete reducibility may be rescued by
the addition of ANF offers a clue to the mechanism of action of this
heterotropic activator [29]. In this study we sought to probe the effect
of CYP3A4 monomerization on the functional heterogeneity revealed
in incomplete reducibility by BMR. In good agreement with our initial
model, monomerization of the enzyme by its incorporation into
lipoprotein Nanodiscs eliminates the heterogeneity and makes the
enzyme completely reducible.
To probe further the effect of CYP3A4 oligomerization in the
membrane on its reducibility we compared two preparations of
liposomes with different lipid:protein ratios. Assuming the average
area of bilayer membrane per one phospholipid molecule to be equal to
72 Å2 (meanvalue for egg phosphatidylcholinemembraneat 30 °C from
Table 3 in [57]) and the footprint of one CYP3A4 molecule to be around
16 nm2, we may calculate that the liposomes LPS-910 contained one
molecule of CYP3A4 per ∼340 nm2 of the lipid bilayer, which
corresponds to the concentration of 0.49 pmol/cm2. Similar calculations
for LPS-76 result in the value of 43 nm2 per CYP3A4 molecule (or the
concentration of 3.9 pmol/cm2). For comparison, according to studies of
Watanabe et al. [58], the total membrane area per one P450molecule in
the endoplasmic reticulumofmouse hepatocytes is in the range of 170–
260 nm2 in the absence of P450 induction and decreases to 60–130 nm2
upon induction with phenobarbital.
According to our results, the reducibility of CYP3A4 in the liposomes
with low surface density of CYP3A4 (LPS-910) was as high 87±9%,
while the liposomes with the high protein density (LPS-76), where the
enzyme is thought to be highly oligomerized, showed total reducibility
of only 55±5%. Therefore, in good agreement with data obtained with
CYP3A4 oligomers and CYP3A4–ND in solution, our experiments with
CYP3A4-containing liposomes suggest that functional heterogeneity of
the enzyme reﬂected in its incomplete reducibility by BMR is caused by
the formation of CYP3A4 oligomers in the membrane.
To probe the reliability of this interpretation we studied the effect
of the surface density of CYP3A4 in the membrane on the state of its
oligomerization. Using a newly developed method based on FRET
from BODIPY ﬂuorophore to the heme groups of the neighboring P450
molecules in the oligomer of CYP3A4(C468)–BODIPY we conﬁrmed
the concentration-dependent formation of the enzyme oligomers in
the liposomal membrane and estimated the value of the apparent Kd
of the oligomer to be of 1.35 pmol/cm2. According to these results, the
fraction of monomeric CYP3A4 in LPS76 (3.9 pmol CYP3A4 per cm2)
and in LPS900 (0.5 pmol/cm2) may be estimated to be around 45%
and 82% respectively. A notable congruence between these values and
the estimates of the enzyme reducibility in these liposomes (55% and
87% respectively) suggests that the efﬁcient transfer of electrons from
BMR to membrane-bound CYP3A4 takes place only in the complexes
of BMR with the monomers of the heme protein. According to the
results of our continuous variation titration experiments with BMR
and LPS-76, the stoichiometry of the BMR–CYP3A4 interactions in
these liposomes is equal to 1:1. The value of Kd for the BMR–CYP3A4
complex (0.14±0.08 µM ) suggests that in the conditions of our
experiments (1.5–3 µM CYP3A4 and a two-fold molar excess of BMR)
the saturation of the heme protein with BMR was virtually complete,
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of the complexes of the redox partners is not functionally competent.
This inference is consistent with the observation of two different
types of complexes of rabbit microsomal cytochrome P450 2B4 with
CPR, only one of which is governed by electrostatic interactions,
whereas the second contact region is hydrophobic [59]. Our
observation is also consistent with the recent indication of multiple
orientations of the ﬂavoprotein in the complexes of the heme domain
of P450BM-3 with the ﬂavodoxin from Desulfovibrio vulgaris (which
served as a model of the FMN domain of BMR) [60].
A plausible hypothesis on the molecular basis of the differences in
the reducibility (or the rate of intracomplex electron transfer) between
the monomers and oligomers of CYP3A4 may be based on our
observation of the effect of CYP3A4 interactions with partially reduced
BMR on the spin state of the heme protein. The results suggested that
the formation of CYP3A4 oligomers, both in solution and in the
membrane, may prevent this ﬂavoprotein-induced spin shift (at least
in some subunits of the oligomeric enzyme) by restricting the
conformational mobility, which is required for this effect to take place.
It should be noted that the ﬁnding that a decrease in the surface
density of CYP3A4 in the liposomes and a subsequent dissociation of
CYP3A4 oligomers renders the reducibility of the enzyme similar to
that observed in the Nanodiscs provides an additional support to our
interpretation of incomplete reducibility as a result of CYP3A4
oligomerization. A close match of the kinetics of reduction of
CYP3A4–ND with that observed in diluted liposomes also suggests
that the difference in the lipid composition between the liposomes
used in these studies, which were composed of a 2:1:0.6 PC:PE:PA
mixture, and the POPC-containing Nanodiscs, is not essential for the
properties of CYP3A4–ND, which lateral mobility is severely restricted
due to immobilization within a thin belt of phospholipids.
The availability of homogeneous monomeric CYP3A4 in Nanodiscs
allowed us to analyze a remarkable intermittent rapid spin shift
processes in the CYP3A4 complex with BMR that precede the heme
protein reduction. Similar transitions were noticed earlier with
CYP3A4 in solution [29] but were not investigated in any detail.
Modulation of the P450 spin state by the state of reduction of the
interacting ﬂavoprotein is consistent with recent indications of a
large-scale conformational transition in NADPH-cytochrome P450
reductase involved in the intra-domain electron transfer [61,62].
The remarkable conformational ﬂexibility of some microsomal
cytochromes P450 [63], close distance (12–18 Å) between the heme
moiety and the isoalloxazine ring of FMN [61,64], and important role
of the dynamics of intramolecular salt bridges in spin transitions of
the heme protein [27,65,66] are all consistent with the hypothesis
that the reduction of FMN may induce a conformational transition in
the heme protein that changes the position of its spin equilibrium.
In particular, such a transition may be triggered by the appearance
of a negative charge on the isoalloxazine ring due to the formation
of the red anionic semiquinone of FMN in BMR.
A transient spin shift in P450 in response to the reduction of the
ﬂavoprotein observed in this study may reveal a novel mechanism of
mutual coordination of substrate binding and the interactions of the
enzyme with the reduced electron donor. In particular, displacement
of the spin equilibrium of the substrate-free enzyme after its binding
to a partially reduced ﬂavoprotein would foster the binding of type-I
substrates, thus preventing a futile cycling of the system. Further-
more, a conversion from the hexa-coordinated low-spin to the penta-
coordinated high-spin state, which is triggered by reduction of the
reductase ﬂavins may have an important impact on the catalytic
efﬁciency and coupling of the P450. This transition is known to
increase the rate of the electron transfer [2,4,5,7] due to a considerable
decrease in the reorganization energy associated with the reduction
process [67,68] along with a positive displacement of the redox
potential of cytochromes P450 [69,70], and 3A4 [71] in particular. At
the same time, the modulation of the spin state of cytochromes P450in response to the changes in the redox state of the reductase may
explain an apparent lack of correlation between the rate of NADPH-
dependent reduction or the rate of substrate turnover and the spin-
state for certain microsomal cytochromes P450 [8], which was
considered as a disproof of the theory of the spin-state control of
the rate of electron transfer. Our results show that the spin state of the
substrate complexes of P450 associated with the reduced reductase
may differ considerably from the spin state of a “resting” enzyme
(reductase-free or associated with the oxidized ﬂavoprotein), which
was employed in probing these correlations.
Therefore, the newly discoveredmodulating effect of the reduction
of the ﬂavoprotein on the spin state may play an important role in ﬁne
tuning of the electron ﬂow from CPR to P450 during the catalytic
cycle. The slow reversal of this transition observed in our experiments
might be speciﬁc for the case of BMR, which is characterized by a very
slow rate of electron transfer to CYP3A4. We may expect that in the
case of complexes of CYP3A4 with its native microsomal reductase
this reversal would be too slow to compete with the intracomplex
electron transfer from the reduced ﬂavoprotein to P450.
Further studies with microsomal CPR would provide proof of the
physiological relevance of the newly discovered modulation of the
spin state of CYP3A4 by the state of reduction of the ﬂavoprotein. A
critical question is whether the electron-donating species of BMR and
CPR to CYP3A4 are different (FMN•− as opposed to FMNH2,
respectively) or whether the role of the anionic semiquinone is a
unique feature of P450–BM3, so that the reduction of CYP3A4 by BMR
occurs through the formation of FMN hydroquinone similar to CPR
[33,51]. The fact that the rate of CYP3A4 reduction by BMR (see
Table 1) is lower than the rate of the formation of semiquinone-
containing species of the ﬂavoprotein in the process of its NADPH-
dependent reduction (see Section 3.2) is consistent with FMNH2 as
electron donor for CYP3A4. Therefore, a similar spin-modulating
mechanism of CYP3A4 by CPR as observed with BMR is anticipated.
In summary, our current results on complete reducibility of
CYP3A4 upon monomerization of the hemeprotein and on the spin
transitions in the enzyme during its reduction may provide a missing
clue to the mysterious difference in the kinetics of reduction of the
low- and high-spin fractions of cytochromes P450. This difference,
which runs counter to the paradigm of rapid spin equilibrium in the
enzyme, remains controversial since its ﬁrst observation over 25 years
ago [4–7,72,73]. Our results may also shed light on the reasons for
striking differences in the kinetics of reduction of various cyto-
chromes P450 and the effects of divergent P450 substrates on such
kinetics [8]. The use of BMR as a model electron donor partner of
CYP3A4 facilitated considerably the resolution of the changes in the
spectra of CYP3A4 from those of the ﬂavoprotein due to the fact that
the intracomplex electron transfer from CPR to CYP3A4 is slow.
Further studies on the relationship between FMN reduction and the
spin state of cytochrome P450 in the complexes of the enzyme with
CPR in Nanodiscs and in liposomal and/ormicrosomalmembranes are
necessary to probe the validity of the newly discovered modulatory
mechanisms for the physiologically relevant microsomal electron
transfer system. Studies of the kinetics of electron transfer in CPR-
containing liposomes at different surface density of the ﬂavoprotein-
saturated CYP3A4 are now in progress.
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